INTEGRILIN

Serial Number 75009658
Registration 2234543
800

Registration Progress

Application Filed
Oct 11, 1995
Under Examination
Jan 6, 1998
Approved for Publication
May 24, 1996
Published for Opposition
Jun 25, 1996
Registered
Mar 23, 1999

Trademark Image

INTEGRILIN

Basic Information

Serial Number
75009658
Registration Number
2234543
Filing Date
October 11, 1995
Registration Date
March 23, 1999
Published for Opposition
June 25, 1996
Renewal Date
March 23, 2019
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 23, 2019
Registration
Registered
Classes
005

Rights Holder

MILLENNIUM PHARMACEUTICALS, INC.

03
Address
40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139

Ownership History

COR Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

COR Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

COR Therapeutics, Inc.

Original Registrant
03
South San Francisco, CA

MILLENNIUM PHARMACEUTICALS, INC.

New Owner After Registration #1
03
CAMBRIDGE, MA

Legal Representation

Attorney
Nancy DiConza

USPTO Deadlines

Next Deadline
1327 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1999-03-23)
Due Date
March 23, 2029
Grace Period Ends
September 23, 2029

Application History

32 events
Date Code Type Description Documents
Apr 23, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 23, 2019 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 23, 2019 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Apr 23, 2019 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Mar 21, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Apr 5, 2017 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Jan 31, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 14, 2008 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
May 14, 2008 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
May 6, 2008 PLGL A ASSIGNED TO PARALEGAL Loading...
Apr 24, 2008 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Mar 8, 2005 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 27, 2005 MAIL I PAPER RECEIVED Loading...
Jan 27, 2005 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Mar 23, 1999 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 30, 1999 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 28, 1999 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 19, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 19, 1999 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 21, 1998 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 21, 1998 IUAF S USE AMENDMENT FILED Loading...
Jul 29, 1998 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 2, 1998 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 6, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 16, 1997 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Oct 16, 1997 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
Aug 8, 1996 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Jul 23, 1996 OPPF T OPPOSITION PAPERS RECEIVED AT TTAB Loading...
Jun 25, 1996 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 24, 1996 NPUB O NOTICE OF PUBLICATION Loading...
Apr 13, 1996 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 12, 1996 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceuticals, namely cardiovascular preparations
First Use Anywhere: 19960200
First Use in Commerce: 19960200

Classification

International Classes
005